# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-127016
Filing Date
2024-11-14
Accepted
2024-11-14 16:02:40
Documents
62
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | spro-20240930.htm iXBRL | 10-Q | 2249239
2 | EX-10.1 | spro-ex10_1.htm | EX-10.1 | 130630
3 | EX-10.2 | spro-ex10_2.htm | EX-10.2 | 56395
4 | EX-10.3 | spro-ex10_3.htm | EX-10.3 | 124311
5 | EX-10.4 | spro-ex10_4.htm | EX-10.4 | 47713
6 | EX-31.1 | spro-ex31_1.htm | EX-31.1 | 10732
7 | EX-31.2 | spro-ex31_2.htm | EX-31.2 | 10879
8 | EX-32 | spro-ex32.htm | EX-32 | 8705
9 | GRAPHIC | img175229707_0.jpg | GRAPHIC | 20001
| Complete submission text file | 0000950170-24-127016.txt |  | 8456053

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | spro-20240930.xsd | EX-101.SCH | 1321107
64 | EXTRACTED XBRL INSTANCE DOCUMENT | spro-20240930_htm.xml | XML | 1069419

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 241461625
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)